GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AFT Pharmaceuticals Ltd (OTCPK:AFTPF) » Definitions » PB Ratio

AFT Pharmaceuticals (AFT Pharmaceuticals) PB Ratio : 0.00 (As of Jun. 20, 2024)


View and export this data going back to 2022. Start your Free Trial

What is AFT Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-20), AFT Pharmaceuticals's share price is $0.00. AFT Pharmaceuticals's Book Value per Share for the quarter that ended in Mar. 2024 was $0.51. Hence, AFT Pharmaceuticals's PB Ratio of today is 0.00.

The historical rank and industry rank for AFT Pharmaceuticals's PB Ratio or its related term are showing as below:

AFTPF' s PB Ratio Range Over the Past 10 Years
Min: 3.35   Med: 12.06   Max: 75
Current: 3.78

During the past 9 years, AFT Pharmaceuticals's highest PB Ratio was 75.00. The lowest was 3.35. And the median was 12.06.

AFTPF's PB Ratio is ranked worse than
77.67% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs AFTPF: 3.78

During the past 12 months, AFT Pharmaceuticals's average Book Value Per Share Growth Rate was 19.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 33.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 69.40% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of AFT Pharmaceuticals was 118.40% per year. The lowest was -43.70% per year. And the median was 33.70% per year.

Back to Basics: PB Ratio


AFT Pharmaceuticals PB Ratio Historical Data

The historical data trend for AFT Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AFT Pharmaceuticals PB Ratio Chart

AFT Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only - - - - -

AFT Pharmaceuticals Quarterly Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AFT Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AFT Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's PB Ratio falls into.



AFT Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

AFT Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=0.00/0.509
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


AFT Pharmaceuticals  (OTCPK:AFTPF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


AFT Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of AFT Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AFT Pharmaceuticals (AFT Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Aqueous cream, Calci-tab, Maxigesic, Cromo-fresh, Crystaderm, Crytawash, Ellgy plus, Emulsifying ointment, and others. The group has four operating segments based on geographical location being, Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia which includes the sales and distribution activity relating to the Australian market.

AFT Pharmaceuticals (AFT Pharmaceuticals) Headlines